584 related articles for article (PubMed ID: 12883837)
1. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
Bechtold H; Gunzenhauser D; Sawitzki H; Fung S; Janssen D
Z Kardiol; 2003 Jul; 92(7):532-9. PubMed ID: 12883837
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
3. [Transesophageal echocardiography in patients with atrial fibrillation, candidates for cardioversion: usefulness and limitations].
Antonielli E; Pizzuti A; Gandolfo N; Bosco M; Sclavo M; Magnacca M; Leonardi G; Doronzo B; Baralis G; Di Leo M
G Ital Cardiol; 1995 May; 25(5):543-52. PubMed ID: 7642059
[TBL] [Abstract][Full Text] [Related]
4. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
Roijer A; Eskilsson J; Olsson B
Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
[TBL] [Abstract][Full Text] [Related]
5. Incidence of cerebral embolism after cardioversion of atrial fibrillation: a prospective study with transesophageal echocardiography and cerebral magnetic resonance imaging.
Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
J Am Soc Echocardiogr; 2005 Jun; 18(6):649-53. PubMed ID: 15947768
[TBL] [Abstract][Full Text] [Related]
6. Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Schmidt-Lucke C; Paar WD; Stellbrink C; Nixdorff U; Hofmann T; Meurer J; Grewe R; Daniel WG; Hanrath P; Mügge A; Klein HU; Schmidt-Lucke JA
Thromb Res; 2007; 119(1):27-34. PubMed ID: 16443257
[TBL] [Abstract][Full Text] [Related]
7. [Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol].
Antonielli E; Pizzuti A; Gandolfo N; Sclavo M; Tanga M; Riva G; Leonardi G; Bassignana A; Di Leo M
G Ital Cardiol; 1997 Aug; 27(8):803-10. PubMed ID: 9312508
[TBL] [Abstract][Full Text] [Related]
8. Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation.
Saeed M; Rahman A; Afzal A; Agoston I; Jammula P; Birnbaum Y; Ware DL; Uretsky BF; Schwarz ER; Rosanio S
Int J Cardiol; 2006 Nov; 113(3):401-5. PubMed ID: 16822564
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: a randomized controlled trial.
Klein AL; Grimm RA; Jasper SE; Murray RD; Apperson-Hansen C; Lieber EA; Black IW; Davidoff R; Erbel R; Halperin JL; Orsinelli DA; Porter TR; Stoddard MF;
Am Heart J; 2006 Feb; 151(2):380-9. PubMed ID: 16442904
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
11. [Anticoagulation in patients with atrial fibrillation].
Mügge A
Herz; 1996 Feb; 21(1):28-36. PubMed ID: 8647577
[TBL] [Abstract][Full Text] [Related]
12. Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study).
Sorino M; Colonna P; De Luca L; Carerj S; Oliva E; De Tommasi SM; Conti U; Iacopi F; D'Agostino C; D'Amato N; Pettinati G; Montericcio V; Cualbu A; De Luca I
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1034-42. PubMed ID: 18163016
[TBL] [Abstract][Full Text] [Related]
13. Use of subcutaneous enoxaparin compared to intravenous heparin and oral phenprocoumon in the setting of cardioversion--the ACE study (Anticoagulation in Cardioversion using Enoxaparin).
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Card Electrophysiol Rev; 2003 Dec; 7(4):382-6. PubMed ID: 15071260
[TBL] [Abstract][Full Text] [Related]
14. [Long-term fate of left atrial thrombi and incidence of cerebral embolism under continuous anticoagulation therapy].
Strach K; Meyer C; Hackenbroch M; Tiemann K; Haase J; Pizulli L; Omran H; Schild H; Sommer T
Rofo; 2005 Dec; 177(12):1706-12. PubMed ID: 16333795
[TBL] [Abstract][Full Text] [Related]
15. A new therapeutic strategy for electrical cardioversion of atrial fibrillation.
de Luca I; Sorino M; Del Salvatore B; de Luca L
Ital Heart J; 2001 Nov; 2(11):831-40. PubMed ID: 11770868
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation with low-molecular-weight heparin in patients with heart diseases.
Bechtold H; Janssen D
Eur J Med Res; 2004 Apr; 9(4):186-98. PubMed ID: 15210399
[TBL] [Abstract][Full Text] [Related]
17. Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging.
Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
J Am Soc Echocardiogr; 2005 Sep; 18(9):919-24. PubMed ID: 16153514
[TBL] [Abstract][Full Text] [Related]
18. Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients: a prospective study with a 1-year follow-up.
de Luca I; Sorino M; De Luca L; Colonna P; Del Salvatore B; Corlianò L
Int J Cardiol; 2005 Jul; 102(3):447-54. PubMed ID: 16004890
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of enoxaparin for anticoagulation in early cardioversion of persisting nonvalvular atrial fibrillation: a statutory health insurance perspective from Germany.
Schädlich PK; Schmidt-Lucke C; Huppertz E; Lehmacher W; Nixdorff U; Stellbrink C; Brecht JG
Am J Cardiovasc Drugs; 2007; 7(3):199-217. PubMed ID: 17610347
[TBL] [Abstract][Full Text] [Related]
20. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
